Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Resumen del perfil de seguridad.
Las reacciones adversas notificadas con mayor frecuencia durante el tratamiento son somnolencia, mareos, dolor de cabeza, palpitaciones, rubor, dolor abdominal, náuseas, hinchazón de tobillos, edema y fatiga.
Lista tabulada de reacciones adversas
Se han observado e informado las siguientes reacciones adversas durante el tratamiento con amlodipino con las siguientes frecuencias: Muy frecuentes (≥1 / 10); común (≥1 / 100 a <1/10); poco frecuentes (≥1 / 1,000 a <1/100); raro (≥1 / 10,000 a <1 / 1,000); Muy raro (<1 / 10,000).
Dentro de cada grupo de frecuencia, las reacciones adversas se presentan en orden decreciente de gravedad:
System organ class |
Frequency |
Adverse reactions |
Blood and lymphatic system disorders |
Very rare |
Leukocytopenia, thrombocytopenia |
Immune system disorders |
Very rare |
Allergic reactions |
Metabolism and nutrition disorders |
Very rare |
Hyperglycaemia |
Psychiatric disorders |
Uncommon |
Depression, mood changes (including anxiety), insomnia |
Rare |
Confusion |
|
Nervous system disorders |
Common |
Somnolence, dizziness, headache (especially at the beginning of the treatment) |
Uncommon |
Tremor, dysgeusia, syncope, hypoaesthesia, paraesthesia |
|
Very rare |
Hypertonia, peripheral neuropathy |
|
Eye disorders |
Common |
Visual disturbance (including diplopia) |
Ear and labyrinth disorders |
Uncommon |
Tinnitus |
Cardiac disorders |
Common |
Palpitations |
Uncommon |
Arrhythmia (including bradycardia, ventricular tachycardia and atrial fibrillation) |
|
Very rare |
Myocardial infarction |
|
Vascular disorders |
Common |
Flushing |
Uncommon |
Hypotension |
|
Very rare |
Vasculitis |
|
Respiratory, thoracic and mediastinal disorders |
Common |
Dyspnoea |
Uncommon |
Cough, rhinitis |
|
Gastrointestinal disorders |
Common |
Abdominal pain, nausea, dyspepsia, altered bowel habits (including diarrhoea and constipation) |
Uncommon |
Vomiting, dry mouth |
|
Very rare |
Pancreatitis, gastritis, gingival hyperplasia |
|
Hepatobiliary disorders |
Very rare |
Hepatitis, jaundice, hepatic enzyme increased* |
Skin and subcutaneous tissue disorders |
Uncommon |
Alopecia, purpura, skin discolouration, hyperhidrosis, pruritus, rash, exanthema, urticaria |
Very rare |
Angioedema, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, Quincke oedema, photosensitivity |
|
Unknown |
Toxic Epidermal Necrolysis |
|
Musculoskeletal and connective tissue disorders |
Common |
Ankle swelling, muscle cramps |
Uncommon |
Arthralgia, myalgia, back pain |
|
Renal and urinary disorders |
Uncommon |
Micturition disorder, nocturia, increased urinary frequency |
Reproductive system and breast disorders |
Uncommon |
Impotence, gynaecomastia |
General disorders and administration site conditions |
Very common |
Oedema |
Common |
Fatigue, asthenia |
|
Uncommon |
Chest pain, pain, malaise |
|
Investigations |
Uncommon |
Weight increased, weight decreased |
* mayormente consistente con colestasis
Se han informado casos excepcionales de síndrome extrapiramidal.
Notificación de sospechas de reacciones adversas.
Es importante informar sospechas de reacciones adversas después de la autorización del medicamento. Permite la monitorización continua del equilibrio beneficio / riesgo del medicamento. Los profesionales de la salud deben informar cualquier sospecha de reacciones adversas a través del Esquema de la Tarjeta Amarilla en www.mhra.gov.uk/yellowcard o buscar la Tarjeta Amarilla MHRA en Google Play o Apple App Store.
PRODUCTOS POR GRUPO : Drogas terminadas > Medicamentos cardiovasculares y urinarios
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.